Maternal anxiety about prenatal screening for group B streptococcus disease and impact of positive colonization results

Cheng, Po‐Jen; Shaw, Sheng-Wen; Lin, Pu; Soong, Yung‐Kuei

doi:10.1016/j.ejogrb.2005.12.018

Cited by 13 publications

(17 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is slightly lower than the values obtained in previous studies of pregnant women 116 and screening for GBS during pregnancy, 75 but within the normal range as indicated by the normative values in the STAI manual (35.2 for working adult women, 36.17 for 19-to 39-year-old women). In a one-way ANOVA, no significant differences in state anxiety were found between those women who tested positive for GBS during pregnancy and those who either were not tested or were tested and displayed a negative result (p > 0.05).…”

Section: Participation In the Study And Anxietycontrasting

confidence: 60%

“…And, in contrast to other fields of antenatal screening, we know little about the psychological impact of GBS screening on mothers. One study, 75 conducted in Taiwan, measured attitudes to testing and the anxiety levels of women routinely tested for GBS between 35 and 37 weeks' gestation. This study found that, although state anxiety rose in women who screened positive, 1 week after delivery anxiety levels had returned to normal, and all mothers supported screening.…”

Section: Acceptability Of Gbs Screeningmentioning

confidence: 99%

“…Nevertheless, evidence of the uptake and impact of these remains scarce. One study, 75 conducted in Taiwan, measured the anxiety levels of women routinely tested for GBS between 35 and 37 weeks' gestation and attitudes to testing. This study found that, although state anxiety rose in women who screened positive, 1 week after delivery anxiety levels had returned to normal.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness

Daniels

Gray²,

Pattison³

et al. 2009

Health Technol Assess

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below).Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeT he Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in t...

show abstract

Section: Participation In the Study And Anxietycontrasting

confidence: 60%

Section: Acceptability Of Gbs Screeningmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness

Daniels

Gray²,

Pattison³

et al. 2009

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…The disadvantages of giving intravenous antibiotics in labour include the development of antibiotic resistance in GBS and other bacteria, and the disruption of the early growth of good bacteria in the newborn's gut (Baltimore, 2007;Centers for Disease Control and Prevention, 2010;Cheng et al, 2006;Daley & Isaacs, 2004;Edwards, 2006;Grimwood et al, 2002;Ohlsson & Shah, 2013;Pattern et al, 2006;Rautava et al, 2012;Russel & Murch, 2006). In the United States and Canada, 20 to 35 per cent of labouring women now receive intravenous antibiotic prophylaxis (Baltimore, 2007;Centers for Disease Control and Prevention, 2010;Chen et al, 2005;Glasglow et al, 2005;Pattern et al, 2006).…”

Section: List Of Figuresmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The impact of oral probiotics on vaginal Group B Streptococcal colonisation rates in pregnant women: A pilot randomised control study

et al. 2018

View full text Add to dashboard Cite

AimThe aim of this study was to complete a pilot project to ascertain if the research design was appropriate to determine whether a daily oral dose of probiotics can reduce the rate of vaginal group B streptococcal (GBS) colonisation in pregnancy. MethodologyA pilot randomised controlled trial was performed which recruited 34 GBS-positive women who were approximately 36 weeks pregnant. The participants were randomly allocated to the control group, who continued with standard antenatal care, or to the intervention group, which continued with standard antenatal care and received a daily oral dose of probiotics for three weeks or until the birth of their infant. A lower vaginal swab to detect the presence of GBS was collected three weeks post consent or when a participant was in labour. ResultsNo significant difference was found in vaginal GBS rates between the control and intervention groups. Only seven of 21 women in the intervention group completed the entire 21 days of probiotics. A subgroup analysis, including only those who had completed 14 days or more of probiotics (n=16), also showed no significant difference in vaginal GBS when compared to the control. As a secondary finding of the analysis did show significantly more vaginal commensals in the probiotics group (p=0.048).iii DiscussionThere are five possible reasons for the lack of significant results: The length of the intervention was too short. The dosage of the probiotics was too low. The wrong strains of probiotics were used. The sample size was inadequate. Oral probiotics are ineffective in impacting vaginal GBS. ImplicationsThe secondary finding of a significant increase of vaginal commensals (normal

show abstract

Evaluation of women's worries in different strategies for the prevention of early onset group B streptococcal disease in neonates

Kolkman

Martin

Jans³

et al. 2020

Midwifery

View full text Add to dashboard Cite

Maternal anxiety about prenatal screening for group B streptococcus disease and impact of positive colonization results

Cited by 13 publications

References 18 publications

Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness

Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness

The impact of oral probiotics on vaginal Group B Streptococcal colonisation rates in pregnant women: A pilot randomised control study

Evaluation of women's worries in different strategies for the prevention of early onset group B streptococcal disease in neonates

Contact Info

Product

Resources

About